Crystallization (Comment) | Organism |
---|---|
enzyme BlaB in complex with the inhibitor D-captopril, hanging drop method, 0.002 ml of 5 mg/ml protein in 10 mM sodium cacodylate, 0.1 mM zinc acetate, 0.1 mM DTT, pH 6.5, is mixed with 0.001 ml of reservoir solution containing 28% PEG 4000, 0.2 M sodium acetate, 0.1 M Tris-HCl, pH 8.4, at 8°C, 3 weeks, complexing by soaking of the crystals in a solution containing 2 mM D-captopril for 5 weeks, cryoprotection by 15% glycerol, X-ray diffraction structure determination and analysis at 1.5 A resolution | Elizabethkingia meningoseptica |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
D-captopril | acts by displacing the catalytic hydroxyl ion required for antibiotic hydrolysis and by intercalating its sulfhydryl group between the 2 Zn2+ ions, the inhibitor molecule is located on one side of the active site cleft | Elizabethkingia meningoseptica |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Zn2+ | metalloenzyme, 2 Zn2+ binding sites | Elizabethkingia meningoseptica |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Elizabethkingia meningoseptica | - |
class B enzyme BlaB, subclass B1 | - |
Subunits | Comment | Organism |
---|---|---|
More | the enzyme shows a typical alphabeta/betaalpha metallo-beta-lactamase fold | Elizabethkingia meningoseptica |
Synonyms | Comment | Organism |
---|---|---|
BlaB | - |
Elizabethkingia meningoseptica |
zinc beta-lactamase | - |
Elizabethkingia meningoseptica |